Rituximab Biosimilars Market: In-Depth Analysis, Emerging Trends,...

added blog News

2024-09-19 04:28:52 - Translate -

The rituximab biosimilars market is gaining substantial momentum due to its critical role in treating autoimmune diseases and various types of cancer, particularly non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. Rituximab, a monoclonal antibody, has been a cornerstone therapy for these conditions, but the high cost of branded biologics has been a significant barrier to access for...

0 Comments 0 Shares 3K Views 0 Reviews